loading
전일 마감가:
$19.16
열려 있는:
$19.19
하루 거래량:
13,186
Relative Volume:
0.03
시가총액:
$520.86M
수익:
$219.79M
순이익/손실:
$-57.47M
주가수익비율:
-8.8488
EPS:
-2.15
순현금흐름:
$-19.25M
1주 성능:
+0.61%
1개월 성능:
+18.17%
6개월 성능:
-31.37%
1년 성능:
-11.26%
1일 변동 폭
Value
$18.82
$19.26
1주일 범위
Value
$18.18
$19.30
52주 변동 폭
Value
$15.45
$35.84

Castle Biosciences Inc Stock (CSTL) Company Profile

Name
명칭
Castle Biosciences Inc
Name
전화
866-788-9007
Name
주소
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
Name
직원
784
Name
트위터
@castlebio
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
CSTL's Discussions on Twitter

CSTL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Diagnostics & Research icon
CSTL
Castle Biosciences Inc
19.04 520.86M 219.79M -57.47M -19.25M -2.15
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
400.39 156.49B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
196.79 145.01B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
532.05 42.30B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
117.61 34.24B 6.63B 1.17B 1.19B 4.05
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
156.84 27.64B 15.50B 1.33B 2.16B 7.34

Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-12-14 개시 Guggenheim Buy
2023-01-05 개시 Scotiabank Sector Outperform
2022-01-07 개시 Stephens Overweight
2021-04-30 개시 Lake Street Buy
2020-11-10 개시 KeyBanc Capital Markets Overweight
2019-12-27 재확인 Canaccord Genuity Buy
2019-08-19 개시 BTIG Research Buy
2019-08-19 개시 Canaccord Genuity Buy
2019-08-19 개시 Robert W. Baird Outperform
2019-08-19 개시 SVB Leerink Outperform
모두보기

Castle Biosciences Inc 주식(CSTL)의 최신 뉴스

pulisher
Jun 18, 2025

Castle Biosciences partners with SciBase for diagnostic tests - MSN

Jun 18, 2025
pulisher
Jun 17, 2025

Castle Biosciences Inc (CSTL) Stock Price Down 4.54% on Jun 17 - GuruFocus

Jun 17, 2025
pulisher
Jun 16, 2025

Castle Biosciences, SciBase Partner to Develop Predictive Tests for Skin Conditions - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase for diagnostic tests (CSTL) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences enters collaboration, license agreement with Scibase to develop diagnostic tests for dermatologic diseases - MarketScreener

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase resolves on a directed share issue of SEK 19 million and announces its intention to carry out an additional directed share issue of approximately SEK 11 million - Yahoo Finance

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement wi - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences (CSTL) Partners with SciBase for Dermatology Advancements | CSTL Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences partners with SciBase to develop atopic dermatitis test - Investing.com

Jun 16, 2025
pulisher
Jun 16, 2025

SciBase signs license agreement with Castle Biosciences to develop dermatology diagnostic tests - marketscreener.com

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License Agreement with SciBase to Develop Diagnostic Tests for Dermatologic Diseases - The Manila Times

Jun 16, 2025
pulisher
Jun 16, 2025

Castle Biosciences Enters Collaboration and License - GlobeNewswire

Jun 16, 2025
pulisher
Jun 16, 2025

New Diagnostic Test Could Predict Atopic Dermatitis Flares Before Symptoms Appear - Stock Titan

Jun 16, 2025
pulisher
Jun 15, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Shares Sold by Harbor Capital Advisors Inc. - Defense World

Jun 15, 2025
pulisher
Jun 14, 2025

Castle Biosciences’ Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - Barchart.com

Jun 14, 2025
pulisher
Jun 11, 2025

Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention | CSTL Stock News - GuruFocus

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences' Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - The Manila Times

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold - GlobeNewswire

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion ... - Bluefield Daily Telegraph

Jun 11, 2025
pulisher
Jun 11, 2025

Castle Biosciences’ Chief Executive Officer Derek Maetzold to Participate in Panel Discussion During the 2025 BIO International Convention - Barchart.com

Jun 11, 2025
pulisher
Jun 08, 2025

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 08, 2025
pulisher
Jun 06, 2025

Two Sigma Advisers LP Acquires New Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 06, 2025
pulisher
Jun 05, 2025

Squarepoint Ops LLC Lowers Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Castle Biosciences' Founder, President and CEO Derek Maetzold Honored with Prestigious Lifetime Achievement Award by The American Business Awards® - The Manila Times

Jun 04, 2025
pulisher
Jun 04, 2025

Castle Biosciences’ Founder, President and CEO Derek - GlobeNewswire

Jun 04, 2025
pulisher
Jun 01, 2025

ProShare Advisors LLC Makes New $230,000 Investment in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

Jun 01, 2025
pulisher
May 30, 2025

Castle Biosciences, Inc. (CSTL) Unveils Largest Real-World Melanoma Risk Study at ASCO 2025 - Insider Monkey

May 30, 2025
pulisher
May 29, 2025

Castle Biosciences Presents Innovative Research on Melanoma Risk Stratification at ASCO 2025 - Nasdaq

May 29, 2025
pulisher
May 29, 2025

New Data at ASCO 2025 Affirms DecisionDx®-Melanoma's - GlobeNewswire

May 29, 2025
pulisher
May 27, 2025

Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Rating of “Buy” by Brokerages - Defense World

May 27, 2025
pulisher
May 27, 2025

Man Group plc Buys Shares of 13,302 Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 27, 2025
pulisher
May 27, 2025

Nuveen Asset Management LLC Has $12.41 Million Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 27, 2025
pulisher
May 24, 2025

Deutsche Bank AG Buys 7,495 Shares of Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 24, 2025
pulisher
May 24, 2025

Bank of America Corp DE Raises Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 24, 2025
pulisher
May 23, 2025

Castle Biosciences amends charter, stockholders vote By Investing.com - Investing.com India

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences Holds Annual Stockholders Meeting - TipRanks

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences amends charter, stockholders vote - Investing.com

May 23, 2025
pulisher
May 23, 2025

Some Confidence Is Lacking In Castle Biosciences, Inc. (NASDAQ:CSTL) As Shares Slide 28% - simplywall.st

May 23, 2025
pulisher
May 23, 2025

Castle Biosciences stock hits 52-week low at $15.66 By Investing.com - Investing.com Australia

May 23, 2025
pulisher
May 23, 2025

Scotiabank Issues Pessimistic Forecast for Castle Biosciences (NASDAQ:CSTL) Stock Price - Defense World

May 23, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Target Price Updated by Scotiabank | C - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Target Price Updated by Scotiabank | CSTL Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences (CSTL) Price Target Revised by Scotiabank | C - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healt - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference | CSTL Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences to Present at the 2025 Jefferies Global Healthcare Conference - The Manila Times

May 21, 2025
pulisher
May 21, 2025

Castle Biosciences Executive Team Reveals Strategic Updates at Jefferies Healthcare Conference - Stock Titan

May 21, 2025
pulisher
May 21, 2025

90,563 Shares in Castle Biosciences, Inc. (NASDAQ:CSTL) Purchased by D. E. Shaw & Co. Inc. - Defense World

May 21, 2025
pulisher
May 21, 2025

Ameriprise Financial Inc. Has $8.42 Million Stock Holdings in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 21, 2025
pulisher
May 19, 2025

Northern Trust Corp Boosts Stock Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 19, 2025
pulisher
May 19, 2025

Jane Street Group LLC Reduces Position in Castle Biosciences, Inc. (NASDAQ:CSTL) - Defense World

May 19, 2025

Castle Biosciences Inc (CSTL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Castle Biosciences Inc 주식 (CSTL) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 21 '25
Sale
21.52
1,236
26,596
74,627
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 09 '25
Sale
20.22
3,647
73,739
4,440
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 09 '25
Sale
20.22
1,023
20,684
75,863
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 08 '25
Sale
20.03
761
15,243
4,577
MAETZOLD DEREK J
Pres. & Chief Exec. Officer
Apr 08 '25
Sale
20.03
213
4,266
76,886
diagnostics_research DGX
$177.88
price down icon 1.03%
diagnostics_research WAT
$346.06
price down icon 0.28%
diagnostics_research LH
$258.76
price down icon 1.46%
$169.31
price down icon 1.26%
diagnostics_research MTD
$1,179.44
price down icon 0.72%
diagnostics_research IQV
$156.93
price down icon 1.02%
자본화:     |  볼륨(24시간):